Pharma 4.0 Continuous mRNA Drug Products Manufacturing
Continuous mRNA drugs manufacturing is perceived to nurture flow processes featuring quality by design, controlled automation, real time validation, robustness, and reproducibility, pertaining to regulatory harmonization. However, the actual adaptation of the latter remains elusive, hence batch-to-c...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2021-08-01
|
| סדרה: | Pharmaceutics |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/1999-4923/13/9/1371 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
